Vertex Pharmaceuticals Inc (VRTX)
450.38
-0.85
(-0.19%)
USD |
NASDAQ |
Nov 21, 16:00
450.38
0.00 (0.00%)
After-Hours: 17:48
Vertex Pharmaceuticals Market Cap: 115.99B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 116.20B |
| November 19, 2024 | 115.38B |
| November 18, 2024 | 120.27B |
| November 15, 2024 | 119.93B |
| November 14, 2024 | 124.63B |
| November 13, 2024 | 127.38B |
| November 12, 2024 | 126.19B |
| November 11, 2024 | 129.21B |
| November 08, 2024 | 133.08B |
| November 07, 2024 | 129.40B |
| November 06, 2024 | 127.13B |
| November 05, 2024 | 128.73B |
| November 04, 2024 | 121.76B |
| November 01, 2024 | 121.33B |
| October 31, 2024 | 122.58B |
| October 30, 2024 | 122.45B |
| October 29, 2024 | 121.23B |
| October 28, 2024 | 122.78B |
| October 25, 2024 | 123.12B |
| October 24, 2024 | 121.63B |
| October 23, 2024 | 121.15B |
| October 22, 2024 | 122.40B |
| October 21, 2024 | 123.22B |
| October 18, 2024 | 124.49B |
| October 17, 2024 | 128.54B |
| Date | Value |
|---|---|
| October 16, 2024 | 125.58B |
| October 15, 2024 | 124.82B |
| October 14, 2024 | 124.96B |
| October 11, 2024 | 124.16B |
| October 10, 2024 | 122.72B |
| October 09, 2024 | 120.61B |
| October 08, 2024 | 118.29B |
| October 07, 2024 | 115.62B |
| October 04, 2024 | 117.35B |
| October 03, 2024 | 116.90B |
| October 02, 2024 | 119.11B |
| October 01, 2024 | 121.08B |
| September 30, 2024 | 119.87B |
| September 27, 2024 | 119.47B |
| September 26, 2024 | 119.54B |
| September 25, 2024 | 119.18B |
| September 24, 2024 | 119.50B |
| September 23, 2024 | 118.73B |
| September 20, 2024 | 120.00B |
| September 19, 2024 | 123.35B |
| September 18, 2024 | 122.38B |
| September 17, 2024 | 124.21B |
| September 16, 2024 | 126.32B |
| September 13, 2024 | 125.28B |
| September 12, 2024 | 123.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
45.35B
Minimum
Oct 05 2021
133.08B
Maximum
Nov 08 2024
77.17B
Average
72.63B
Median
Jul 25 2022
Market Cap Benchmarks
| Gilead Sciences Inc | 111.91B |
| Eli Lilly and Co | 711.90B |
| Bristol-Myers Squibb Co | 118.12B |
| Moderna Inc | 14.72B |
| Pfizer Inc | 142.44B |
Market Cap Related Metrics
| PS Ratio | 11.03 |
| Price to Book Value | 7.420 |
| Price | 450.38 |
| Earnings Yield | -0.44% |
| Operating PE Ratio | 27.65 |
| Normalized PE Ratio | 38.08 |